|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07H 19/00 | |
| C07H 19/06 | |||
| C07H 19/20 | |||
| C07H 19/16 | |||
| A61K 31/7068 | |||
| A61K 31/7072 | |||
| A61K 31/7076 | |||
| A61K 31/708 | |||
| A61P 31/04 |
| (11) | Patento numeris | 2906579 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13776706.7 |
| Europos patento paraiškos padavimo data | 2013-10-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/063731 |
| Data | 2013-10-07 |
| (87) | Numeris | WO 2014/058801 |
| Data | 2014-04-17 |
| (30) | Numeris | Data | Šalis |
| 201261711131 P | 2012-10-08 | US | |
| 201361807249 P | 2013-04-01 | US |
| (72) |
GOSSELIN, Gilles, FR
PARSY, Christophe Claude, FR
ALEXANDRE, Francois-Rene, FR
RAHALI, Houcine, FR
GRIFFON, Jean-Franēois, FR
SURLERAUX, Dominique, BE
DOUSSON, Cyril B., FR
PIERRA, Claire, FR
MOUSSA, Adel M., US
MAYES, Benjamin Alexander, US
STEWART, Alistair James, US
DUKHAN, David, FR
|
| (73) |
Centre National de la Recherche Scientifique (C.N.R.S.),
3 rue Michel-Ange, 75794 Paris Cedex 16,
FR
Université de Montpellier, 163 rue Auguste Broussonnet, 34090 Montpellier, FR Idenix Pharmaceuticals LLC, 320 Bent Street, Floor 4, Cambridge, MA 02141, US |
| (54) | 2`-CHLORO NUCLEOSIDE ANALOGS FOR HCV INFECTION |
| 2`-CHLORO NUCLEOSIDE ANALOGS FOR HCV INFECTION |